Kids and Carers
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Children and their Carers who wish to know more on Antimicrobial resistance, aim to set up child-oriented activities to increase the awareness on AMR or otherwise will be involved in preventing Antimicrobial resistance in children, AMR Insights offers selected, global information on activities, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Children
- Carers and parents
- Teachers
- Organizers of AMR events for children
- Pediatricians
Latest Topics
-
24 December 2024Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to assess the global prevalence of antibiotic resistance in pediatric Helicobacter pylori infection. The study found that primary resistance rates were metronidazole 35.3%, clarithromycin 32.6%, tetracycline 2.1%, levofloxacin 13.2%, and amoxicillin 4.8%. Raising antibiotic resistance was detected in most WHO regions. The escalating trend of H. pylori antibiotic resistance […]
Read more... -
21 November 2024Reducing antibiotic use with diarrhoeal vaccines
Diarrhoeal disease is the third leading cause of death among children under five years globally, with 11.7 billion cases occurring annually, resulting in over 500,000 deaths. Antimicrobial resistance (AMR) is a major global health and development threat, exacerbated by the misuse and overuse of antibiotics. A study comparing six individual and three combination vaccines against […]
Read more... -
21 November 2024Accelerating optimal approval of priority formulations for antibiotic use in children: meetings report, 7 December 2023 and 19-20 March 2024
In order to fill important gaps in age-appropriate therapies for babies and children, WHO released the first-ever list of priority pediatric formulations for antibiotics on March 24, 2023. This list of antibiotics that urgently require development to treat infections from high-priority pathogens was created using WHO’s Paediatric Drug Optimisation (PADO) approach. In order to speed […]
Read more...
More news related to Kids and Carers